Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial
Go back to Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 2.79 +0.01 (0.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.78 | 52 Week High | $9.09 | |||
| Open | $2.73 | 52 Week Low | $4.02 | |||
| Day High | $2.87 | P/E | N/A | |||
| Day Low | $2.65 | EPS | $-0.05 | |||
| Volume | 28,183 | |||||
